Clinical and paraclinical outcomes of SARS-CoV-2 variants in neonates and infants - Payesh (Health Monitor)
Wed, Jul 10, 2024
OPEN ACCESS
Volume 23, Issue 3 (May-June 2024)                   Payesh 2024, 23(3): 481-483 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Arefinia N, Mousavi M J, Teimouri H, Fakhrizadeh M, Zeynali P. Clinical and paraclinical outcomes of SARS-CoV-2 variants in neonates and infants. Payesh 2024; 23 (3) :481-483
URL: http://payeshjournal.ir/article-1-2230-en.html
1- Department of Medical Microbiology, Jiroft University of Medical Sciences, Jiroft, Iran
2- Department of Hematology, School of Para-Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
3- Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
4- Department of Basic Medical Sciences, Khoy University of Medical Sciences, Khoy, Iran
Abstract:   (248 Views)
Dear Editor,
With the global spread of the COVID-19 pandemic, symptoms such as fever, cough, myalgia, and fatigue, along with laboratory findings of leukocyte count abnormalities and chest radiographic evidence, have been reported as nonspecific symptoms in various variants. Fever was the most common symptom in all variants of the SARS-CoV-2 virus, although evidence suggest that children with the beta variant experienced less fever. Other manifestations, such as diarrhea, vomiting, abdominal pain, and dizziness, have been less common, but may sometimes be the only symptom. In a systematic review on the characteristics of infants with SARS-CoV-2 infection in England, it was reported that the main symptoms at presentation were heatstroke, poor feeding, vomiting, respiratory symptoms, crysis, and lethargy. The clinical symptoms of COVID-19 in children vary depending on the virus variant and correspond to the World Health Organization peak variants of concern. Therefore, clinical guidelines are recommended to perform protected deliveries and reduce the possibility of contracting Covid-19 during delivery and after delivery in infected pregnant women. Standardized testing protocol, avoiding mother-to-child transmission, and providing the best treatment for symptomatic infants are central issues in the management of infections in infants and children with suspected or suspected COVID-19. It is better to use breast milk in the form of expressed milk or powdered milk. PCR-positive neonates should be admitted to a negative pressure isolation room and provided with intubation or airway management services.
Full-Text [PDF 421 kb]   (130 Downloads)    
Subject: Letter to editor
Received: 2023/07/22 | Accepted: 2023/11/14 | ePublished ahead of print: 2024/06/1 | Published: 2024/06/1

References
1. Emadi MS, Soltani S, Noori B, Zandi M, Shateri Z, Tabibzadeh A, Behboudi E, Erfani Y, Tabaeian SP, Pourhossein B, Didehdar M. Highly conserve sequences in envelope, nucleoprotein and RNA-dependent RNA polymerase of SARS-CoV-2 in nasopharyngeal samples of the COVID-19 patients; a diagnostic target for further studies. Journal of Cellular & Molecular Anesthesia 2022;7:78-83
2. Zandi M, Behboudi E, Shojaei MR, Karami H. Letter to the editor regarding" an overview on serology and molecular tests for COVID-19: an important challenge of the current century (doi: 10.22034/iji.2021.88660.1894.)". Iranian Journal of Immunology 2022;19:337
3. Behboudi E, Hamidi V, Gholizadeh F, Grala EM, Ghelmani Y, Nakhaie M, Charostad J, Astani A. Association between ABO blood groups and rhesus antigen and susceptibility to COVID-19 in the Yazd hospital. New Microbes and New Infections 2021;44:100934 [DOI:10.1016/j.nmni.2021.100934]
4. Zandi M, Behboudi E, Soltani S. Role of glycoprotein hemagglutinin-esterase in COVID-19 pathophysiology?. Stem Cell Reviews and Reports 2021;17:2359-60 [DOI:10.1007/s12015-021-10210-1]
5. Behboudi E, Mokhtari-Azad T, Yavarian J, Ghavami N, Khorrami SM, Rezaei F, Charostad J, Malekshahi SS, Shafiei-Jandaghi NZ. Molecular detection of HHV1-5, AAV and HPV in semen specimens and their impact on male fertility. Human Fertility 2019;22:133-8 [DOI:10.1080/14647273.2018.1463570]
6. Esfahanian N, Shirvani F, Bazgir N, Karimi A, Tabatabaei SR, Armin S, Fahimzad SA, Ghanaiee RM, Esfahanian Y. Investigation of Clinical Manifestations and Laboratory Findings of COVID-19 During National Peaks of Alpha, Beta, Delta, and Omicron in the Pediatric Emergency Department of Mofid Children's Hospital, Tehran, Iran. Archives of Pediatric Infectious Diseases 2023 [In Press] [DOI:10.5812/pedinfect-134554]
7. Dyer O. Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show. BMJ 2021;375:n3104 [DOI:10.1136/bmj.n3104]
8. Cloete J, Kruger A, Masha M, du Plessis NM, Mawela D, Tshukudu M, et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. The Lancet Child & Adolescent Health 2022;6:294-302 [DOI:10.1016/S2352-4642(22)00027-X]
9. Christophers B, Gallo Marin B, Oliva R, Powell WT, Savage TJ, Michelow IC. Trends in clinical presentation of children with COVID-19: a systematic review of individual participant data. Pediatric Research 2022;91:494-501 [DOI:10.1038/s41390-020-01161-3]
10. Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M. Advances in the Omicron variant development. Journal of Internal Medicine 2022;292:81-90 [DOI:10.1111/joim.13478]
11. Zandi M, Hosseini F, Adli AH, Salmanzadeh S, Behboudi E, Halvaei P, Khosravi A, Abbasi S. State-of-the-art cerium nanoparticles as promising agents against human viral infections. Biomedicine & Pharmacotherapy 2022;156:113868 [DOI:10.1016/j.biopha.2022.113868]
12. Sahebi S, Keikha M. Clinical features of SARS-CoV-2 Omicron BA. 2; Lessons from previous observations-correspondence. International Journal of Surgery (London England) 2022;104:106754 [DOI:10.1016/j.ijsu.2022.106754]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Payesh (Health Monitor)

Designed & Developed by : Yektaweb